Your browser doesn't support javascript.
loading
Long non-coding RNA LINC00565 regulates ADAM19 expression through sponging microRNA-532-3p, thereby facilitating clear cell renal cell carcinoma progression.
Meng, Bin; Wang, Pengfei; Zhao, Chaofei; Yin, Guangwei; Meng, Xin; Li, Lin; Cai, Shengyong; Yan, Chengquan.
Affiliation
  • Meng B; Department of Urology, Tangshan Gongren Hospital, Tangshan, China.
  • Wang P; Department of Urology, Tangshan Gongren Hospital, Tangshan, China.
  • Zhao C; Department of Urology, Tangshan Gongren Hospital, Tangshan, China.
  • Yin G; Department of Urology, Tangshan Gongren Hospital, Tangshan, China.
  • Meng X; Department of Urology, Tangshan Gongren Hospital, Tangshan, China.
  • Li L; Department of Urology, Tangshan Gongren Hospital, Tangshan, China.
  • Cai S; Department of Urology, Tangshan Gongren Hospital, Tangshan, China.
  • Yan C; Department of Urology, Tangshan Gongren Hospital, Tangshan, China.
Chin J Physiol ; 66(6): 474-484, 2023.
Article in En | MEDLINE | ID: mdl-38149560
ABSTRACT
Proven by publications, long non-coding RNAs (lncRNAs) play critical roles in the development of clear cell renal cell carcinoma (ccRCC). Although lncRNA LINC00565 has been implicated in the progression of various cancers, its biological effects on ccRCC remain unknown. This study aimed to investigate the biological functions of LINC00565, as well as its potential mechanism in ccRCC. Here, the expression data of mature microRNAs (miRNAs) (normal 71, tumor 545), messenger RNAs (mRNAs), and lncRNAs (normal 72, tumor 539) of ccRCC were acquired from The Cancer Genome Atlas (TCGA) database and subjected to differential expression analysis. Quantitative reverse transcriptase polymerase chain reaction analyzed the expression levels of LINC00565, miR-532-3p, and ADAM19 mRNA. TCGA database, dual-luciferase report detection, and Argonaute 2 RNA immunoprecipitation were utilized to confirm the relationships between LINC00565 and miR-532-3p and between miR-532-3p and ADAM19, respectively. The progression of ccRCC cells was determined via CCK-8, colony formation, scratch healing, and transwell assays. Western blot was applied to detect the protein levels of epithelial-mesenchymal transition markers and ADAM19. We herein suggested that LINC00565 was prominently upregulated in ccRCC tissues and cells. Knockdown of LINC00565 repressed cell progression. We further predicted and validated miR-532-3p as a target of LINC00565, and miR-532-3p could target ADAM19. Knockdown of LINC00565 resulted in ADAM19 level downregulation in ccRCC cells and suppressed miR-532-3p could restore ADAM19 level. Thus, the three RNAs constructed a ceRNA network. Overexpressed ADAM19 could eliminate the anticancer effects caused by knocking down LINC00565 on ccRCC cells. In conclusion, LINC00565 upregulated ADAM19 via absorbing miR-532-3p, thereby facilitating the progression of ccRCC cells.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / MicroRNAs / RNA, Long Noncoding / Kidney Neoplasms Limits: Humans Language: En Journal: Chin J Physiol Year: 2023 Document type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / MicroRNAs / RNA, Long Noncoding / Kidney Neoplasms Limits: Humans Language: En Journal: Chin J Physiol Year: 2023 Document type: Article Affiliation country: China